Commercializing a global rare disease therapeutic comes with unique challenges that are often underestimated.

In this MM+M e-book, Bill McEllen, Global President of Fingerpaint, is joined by Scott Watson, Creative Lead at Fingerpaint Marketing, in an exploration of the marketing and creative considerations that ensure rare disease campaigns reach their highest potential.